2cureX receives third payment from the EU’ Horizon 2020 SME- Instrument Program
2cureX AB (“2cureX”) today announces that the company has received a third payment of EUR 596,886 from the EU’s Horizon 2020 SME Program . The grant is given to finalize the clinical validation of the company’s IndiTreat® product and to initiate market launch.As previously communicated, 2cureX has in February 2018 started a project funded with a EUR 3 million grant from the EU’s Horizon 2020 SME Program. Partners in the project are cancer hospitals in Denmark, Germany, the United Kingdom and Sweden as well as the patient organization